ImageneBio, Inc. (IMA) - Latest Market Data

Price & Market Data

Price: $5.72

Daily Change: +$0.11 / 1.92%

Daily Range: $5.50 - $5.76

Market Cap: $64,516,620

Daily Volume: 10,810

Performance Metrics

1 Week: -1.89%

1 Month: -5.45%

3 Months: -21.54%

6 Months: -31.00%

1 Year: -58.19%

YTD: -17.10%

About ImageneBio, Inc. (IMA)

Get the full picture of ImageneBio, Inc. (IMA). Price: 5.72, daily change: +$0.11 / 1.92%. Market cap: 64,516,620. All performance metrics from 1-week to 1-year are here.

Company Details

Employees: 15

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

ImageneBio, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for patients with immunological, autoimmune and inflammatory diseases. Its lead product candidate includes IMG-007, a non-depleting anti-OX40 monoclonal antibody that binds to OX40 receptor on activated T cells to block receptor binding to OX40 ligand which is in Phase 1b/2a clinical trial. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

Selected stocks

Reading International Inc (RDIB)

Immuron Limited (IMRN)

Asia Pacific Wire & Cable Corporation Limited (APWC)

Drugs Made In America Acquisition Corp. (DMAA)